Machine Learning for Treatment Assignment: Improving Individualized Risk Attribution.

Area of Science:

• Biostatistics
• Machine Learning in Medicine
• Causal Inference

Background:

• Clinical studies often estimate the average treatment effect (ATE), a population-level metric.
• Applying ATE to individual patients may lack precision and applicability.
• Recent machine learning advancements enable more personalized effect estimation.

Purpose of the Study:

• To advocate for individualized treatment effect (ITE) modeling over ATE.
• To compare machine learning-based ITE estimation with traditional ATE methods.
• To demonstrate the theoretical generalization advantages of ITE for new populations.

Main Methods:

• Comparison of ATE estimation (randomized and observational) with machine learning-based ITE estimation.
• Utilized a synthetic dataset on statin use and myocardial infarction (MI).
• Employed a consistent, nonparametric algorithm from unweighted examples for ITE models.
• Validated findings with a real-world dataset on D-penicillamine for primary biliary cirrhosis.

Main Results:

• Learned ITE models demonstrated improved true ITE estimation compared to ATE.
• ITE models outperformed ATE in predictive accuracy on the synthetic dataset.
• Experiments supported the use of consistent, nonparametric algorithms for ITE learning.

Conclusions:

• Individualized treatment effect (ITE) modeling offers superior applicability and generalization for future patients.
• Machine learning-based ITE estimation is a promising alternative to traditional ATE.
• ITE models learned from unweighted examples using consistent, nonparametric methods are recommended.